The treatment extended the lifespan of rats by 25%, lowering cancer risk, preventing grey hair, improving vision, and enhancing muscle functionality.
The developed drug that switches off interleukin-11 protein led to healthier old mice with reduced muscle wasting, improved muscle strength, and increased lifespan.
Anti-IL-11 treatments showed promising results in mice, hinting at potential similar effects in aging humans, with the drug being considered safe for human use in ongoing trials.
Collection
[
|
...
]